First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in metastatic non-small cell lung cancer: CheckMate 9LA 2-year patient-reported outcomes
| Title | First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in metastatic non-small cell lung cancer: CheckMate 9LA 2-year patient-reported outcomes |
|---|---|
| Description | This study will publish its results in European Journal of Cancer. |
| Organism | Homo sapiens |
| Data Type | Biomarker Data |
| Data Accessibility | Controlled-access |
| BioProject | PRJCA011385 |
| Release Date | 2023-06-30 |
| Submitter | nan zhao (1165095416@qq.com) |
| Organization | Jilin Cancer Hospital |
| Submission Date | 2022-12-05 |
HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client).
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download Times | Download |
|---|---|---|---|---|---|---|---|
| OMIX002518-01 | CM9LA - Results in EJO | 1 | Biomarker Data | 543.5 KB | 0 | Controlled |